Kathryn B. Holroyd - Publications

Affiliations: 
Johns Hopkins University School of Medicine, Baltimore, MD, United States 

1/29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Holroyd KB, Adrover MF, Fuino RL, Bock R, Kaplan AR, Gremel CM, Rubinstein M, Alvarez VA. Loss of feedback inhibition via D2 autoreceptors enhances acquisition of cocaine taking and reactivity to drug-paired cues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1495-509. PMID 25547712 DOI: 10.1038/Npp.2014.336  0.348
Low-probability matches (unlikely to be authored by this person)
2013 Havrda MC, Paolella BR, Ward NM, Holroyd KB. Behavioral abnormalities and Parkinson's-like histological changes resulting from Id2 inactivation in mice. Disease Models & Mechanisms. 6: 819-27. PMID 23264561 DOI: 10.1242/Dmm.010041  0.268
2020 Holroyd KB, Manzano GS, Levy M. Update on neuromyelitis optica spectrum disorder. Current Opinion in Ophthalmology. 31: 462-468. PMID 33009077 DOI: 10.1097/Icu.0000000000000703  0.253
2018 Holroyd KB, Aziz F, Szolics M, Alsaadi T, Levy M, Schiess N. Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study. Clinical & Experimental Neuroimmunology. 9: 155-161. PMID 30090123 DOI: 10.1111/Cen3.12458  0.221
2020 Mateen FJ, Vogel AC, Kaplan TB, Hotan GC, Grundy SJ, Holroyd KB, Manalo N, Stauder M, Videnovic A. Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial. Journal of Neurology. PMID 32333168 DOI: 10.1007/S00415-020-09845-W  0.202
2019 Holroyd K, Vogel A, Lynch K, Gazdag B, Voghel M, Alakel N, Patenaude BN, Chiong-Rivero H, Mateen FJ. Neuromyelitis optica testing and treatment: Availability and affordability in 60 countries. Multiple Sclerosis and Related Disorders. 33: 44-50. PMID 31154260 DOI: 10.1016/J.Msard.2019.05.013  0.2
2019 Schiess N, Huether K, Holroyd KB, Aziz F, Emam E, Shahrour T, Szolics M, Alsaadi T. Multiple Sclerosis, Anxiety, and Depression in the United Arab Emirates: Does Social Stigma Prevent Treatment? International Journal of Ms Care. 21: 29-34. PMID 30833870 DOI: 10.7224/1537-2073.2017-041  0.198
2020 Holroyd KB, Manzano GS, Levy M. Update on neuromyelitis optica spectrum disorder. Current Opinion in Ophthalmology. PMID 32897922 DOI: 10.1097/ICU.0000000000000703  0.184
2017 Al Dhaibani MA, El-Hattab AW, Holroyd KB, Orthmann-Murphy J, Larson VA, Siddiqui KA, Szolics M, Schiess N. Novel mutation in the KCNJ10 gene in three siblings with seizures, ataxia and no electrolyte abnormalities. Journal of Neurogenetics. 1-5. PMID 29191078 DOI: 10.1080/01677063.2017.1404057  0.179
2023 Holroyd KB, Conway SE. Central Nervous System Neuroimmunologic Complications of COVID-19. Seminars in Neurology. PMID 37080234 DOI: 10.1055/s-0043-1767713  0.172
2016 Holroyd KB, Rittenberg A, Pahwa A. Further Misanalysis of Urinalysis-Reply. Jama Internal Medicine. 176: 1408. PMID 27598759 DOI: 10.1001/Jamainternmed.2016.4510  0.153
2016 Holroyd KB, Rittenberg A, Pahwa A. Misanalysis of Urinalysis: A Teachable Moment. Jama Internal Medicine. 176: 432-3. PMID 26954774 DOI: 10.1001/Jamainternmed.2016.0067  0.147
2022 Conway SE, Pua DKA, Holroyd KB, Galetta K, Bhattacharyya S. Neurologic disease activity in people with multiple sclerosis treated with immune checkpoint inhibitors. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221117949. PMID 35957594 DOI: 10.1177/13524585221117949  0.096
2022 Manzano GS, Holroyd KB, Kaplan T, Bhattacharyya S, Chitnis T, Hotan G, Zurawski J, Galetta KM, Mateen FJ. Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series. Multiple Sclerosis and Related Disorders. 63: 103861. PMID 35576727 DOI: 10.1016/j.msard.2022.103861  0.096
2022 Holroyd KB, Healy BC, Conway S, Houtchens M, Bakshi R, Bhattacharyya S, Bose G, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Polgar-Turcsanyi M, Saxena S, et al. Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes. Multiple Sclerosis and Related Disorders. 67: 104079. PMID 35952457 DOI: 10.1016/j.msard.2022.104079  0.091
2021 Holroyd KB, Rubin DB, Vaitkevicius H. Neurologic Complications in Patients with Cancer. Seminars in Neurology. 41: 588-605. PMID 34619783 DOI: 10.1055/s-0041-1733788  0.085
2024 Holroyd KB, Berkowitz AL. Metabolic and Toxic Myelopathies. Continuum (Minneapolis, Minn.). 30: 199-223. PMID 38330479 DOI: 10.1212/CON.0000000000001376  0.082
2017 Holroyd KB, Sotirchos ES, DeBoer SR, Mills KA, Newsome SD. JC virus granule cell neuronopathy onset two months after chemotherapy for low-grade lymphoma. Cerebellum & Ataxias. 4: 8. PMID 28652923 DOI: 10.1186/s40673-017-0066-6  0.076
2023 Rice DR, Holroyd KB, Pua DK, Levy M, Mateen FJ, Bhattacharyya S. Quantifying the economic burden to patients of relapse events from neuromyelitis optica spectrum disorders: A cross-sectional survey. Multiple Sclerosis and Related Disorders. 71: 104580. PMID 36805175 DOI: 10.1016/j.msard.2023.104580  0.066
2023 Holroyd KB, Berkowitz AL. Historical Perspectives on the Neurologic Manifestations of Viral Pandemics. Seminars in Neurology. PMID 37037211 DOI: 10.1055/s-0043-1767714  0.058
2024 Holroyd KB, Han WM, Apornpong T, Trautmann L, Gatechompol S, Hiransuthikul A, Ubolyam S, Sacdalan C, Sriplienchan S, Kanaprach R, Kerr S, Avihingsanon A, Spudich S, Chan P. Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART. Hiv Medicine. PMID 38383057 DOI: 10.1111/hiv.13621  0.052
2020 Holroyd KB, Vishnevetsky A, Srinivasan M, Saylor D. Neurologic Complications of Acute HIV Infection. Current Treatment Options in Infectious Diseases. 12: 227-242. PMID 33551684 DOI: 10.1007/s40506-020-00228-3  0.048
2021 Normandin E, Holroyd KB, Collens SI, Shaw BM, Siddle KJ, Adams G, Rudy M, Solomon IH, Anahtar MN, Lemieux JE, Trombetta BA, Kivisakk P, Arnold SE, Rapalino O, Piantadosi AL, et al. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients. Journal of the Neurological Sciences. 430: 120023. PMID 34678659 DOI: 10.1016/j.jns.2021.120023  0.046
2021 Márquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain- Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality. Neurology. PMID 33824169 DOI: 10.1212/WNL.0000000000011881  0.045
2023 Han WM, Hiransuthikul A, Holroyd KB, Apornpong T, Lwin HM, Gatechompol S, Ubolyam S, Kerr S, Avihingsanon A. Impact of steatotic liver disease and non-alcoholic steatohepatitis on cognitive impairment in people living with HIV: A cross-sectional study. Hiv Medicine. 24: 1233-1243. PMID 37975283 DOI: 10.1111/hiv.13579  0.035
2019 Eberly LA, Richterman A, Beckett AG, Wispelwey B, Marsh RH, Cleveland Manchanda EC, Chang CY, Glynn RJ, Brooks KC, Boxer R, Kakoza R, Goldsmith J, Loscalzo J, Morse M, Lewis EF, ... ... Holroyd K, et al. Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center. Circulation. Heart Failure. 12: e006214. PMID 31658831 DOI: 10.1161/Circheartfailure.119.006214  0.034
2022 Holroyd KB, Rubin DB, LaRose S, Monk A, Nikiforow S, Jacobson C, Vaitkevicius H. Use of Transcranial Doppler as a Biomarker of CAR T Cell-Related Neurotoxicity. Neurology. Clinical Practice. 12: 22-28. PMID 36157627 DOI: 10.1212/CPJ.0000000000001130  0.031
2015 Holroyd KB, Fosdick L, Smith GS, Leoutsakos JM, Munro CA, Oh ES, Drake KE, Rosenberg PB, Anderson WS, Salloway S, Pendergrass JC, Burke AD, Wolk DA, Tang-Wai DF, Ponce FA, et al. Deep brain stimulation targeting the fornix for mild Alzheimer dementia: Design of the ADvance randomized controlled trial Open Access Journal of Clinical Trials. 7: 63-76. DOI: 10.2147/Oajct.S81542  0.029
2021 Budhu J, Holroyd K, Balaban D, Yau WW, Doughty C, Miyawaki E, Rennke H, Amato A. Clinical Reasoning: A 63-Year-Old Woman Presenting With Bilateral Leg Pain. Neurology. 96: 343-348. PMID 33208546 DOI: 10.1212/WNL.0000000000011220  0.027
Hide low-probability matches.